4//SEC Filing
Hasnain Faheem 4
Accession 0000950170-25-043903
CIK 0001422143other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:33 PM ET
Size
6.5 KB
Accession
0000950170-25-043903
Insider Transaction Report
Form 4
Hasnain Faheem
Director
Transactions
- Exercise/Conversion
Common Stock
2025-03-21$6.32/sh+22,682$143,350→ 46,665 total - Sale
Common Stock
2025-03-21$8.00/sh−22,682$181,456→ 23,983 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 20, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $8.00 to $8.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001352620
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 4:33 PM ET
- Size
- 6.5 KB